Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 80Lymphoid 68CNS 53Dermatologic 50Genitourinary 42Breast 42Myeloid 34Sarcoma 32Plasma cell 28Gastrointestinal 26Gynecologic 24Thoracic 22Other solid neoplasm 10Classical hematology 10Head & Neck 9Tumor-Agnostic 4Other neoplasm 1Endocrine 1

Conditions

Neoplasm Metastasis 3Adenocarcinoma 2Neoplasms 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × sargramostim × Tumor-Agnostic × Clear all
NCT04739618 2024-07-23

Metastatic Solid Cancer Clinical Trial

ImmunSYS, LLC

Phase 2 Active not recruiting
32 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05101356 2024-05-21

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

University of California, Davis

Phase 1/2 Recruiting
77 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

NCT04713371 2024-05-09

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Rampart Health, L.L.C.

Phase 2 Unknown
32 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01342224 2018-04-12

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Providence Health & Services

Phase 1 Completed
11 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡